Search Within

Connie Wing-Ching Lee Batlevi

Formats
  1. Meeting Abstract (109)
  2. Journal Article (52)
  3. Research Letter (5)
  4. Book Section (4)
  5. Miscellaneous (2)
  6. Review (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (176)
  2. Department of Medicine (176)
  3. Hematologic Malignancies, Division of (176)
  4. Lymphoma (176)
  5. Survivorship Research (117)
  6. Epidemiology and Biostatistics (89)

More Groups

People
  1. Maria Palomba (98)
  2. Anas Younes (81)
  3. Andrew Zelenetz (76)
  4. Matthew Matasar (70)
  5. David Straus (61)
  6. Ariela Noy (60)

More People

Years
  1. 2024 (2)
  2. 2023 (11)
  3. 2022 (30)
  4. 2021 (27)
  5. 2020 (27)
  6. 2019 (34)

More Years

Publications
  1. Blood (69)
  2. Hematological Oncology (16)
  3. Blood Advances (12)
  4. Journal of Clinical Oncology (10)
  5. Blood Cancer Journal (6)
  6. Biology of Blood and Marrow Transplantation (5)

More Publications

Publishers
  1. American Society of Hematology (82)
  2. Wiley Blackwell (16)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (15)
  5. American Society of Clinical Oncology (10)
  6. John Wiley & Sons (4)

More Publishers

Results (176)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SNP arrays and targeted genomic sequencing identify distinctive genomic alterations in testicular diffuse large B-cell lymphoma
    Meeting Abstract

    Gur, D.; Batlevi, C.; Rapaport, F.; Wang, L.; Jungbluth, A.; Pichardo, J.; Arcila, M. E.; Zelenetz, A. D.; Younes, A.; Dogan, A.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Utility of oral fluid (saliva) for molecular profiling in hematologic malignancy
    Meeting Abstract

    Killian, J.; Arcila, M. E.; Batlevi, C.; Ladanyi, M.; Meltzer, P.; Ptashkin, R.; Younes, A.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • SNP arrays and targeted genomic sequencing identify distinctive genomic alterations in testicular diffuse large B-cell lymphoma
    Meeting Abstract

    Gur, D.; Batlevi, C.; Rapaport, F.; Wang, L.; Jungbluth, A.; Pichardo, J.; Arcila, M. E.; Zelenetz, A. D.; Younes, A.; Dogan, A.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Novel immunotherapies in lymphoid malignancies
    Journal Article

    Batlevi, C. L.; Matsuki, E.; Brentjens, R. J.; Younes, A.
    Nature Reviews Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Distinctive genomic alterations in testicular diffuse large B cell lymphoma
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Wang, L.; Intlekofer, A. M.; Copeland, A. R.; Jungbluth, A. A.; Reiner, A.; Pichardo, J. D.; Gallagher, M.; Bouvier, N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Hodgkin lymphoma microenvironment: Old and new therapeutic targets
    Book Section

    Batlevi, C. L.; Younes, A.
    In Carbone, A.; Younes, A. (Eds.) Hodgkin and Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (2015)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) and LDH as prognostic factors in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing during or following docetaxel treated in the orteronel phase 3 ELM-PC 5 trial
    Meeting Abstract

    Scher, H. I.; Fizazi, K.; Lee, C.; Maclean, D.; Tejura, B.; Webb, I. J.; Borgstein, N.; Dreicer, R.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save